The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model

IntroductionVaccination is the most effective mechanism to prevent severe COVID-19. However, breakthrough infections and subsequent transmission of SARS-CoV-2 remain a significant problem. Intranasal vaccination has the potential to be more effective in preventing disease and limiting transmission b...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2023-08, Vol.14, p.1188392-1188392
Main Authors: Dickson, Alexandria, Geerling, Elizabeth, Stone, E. Taylor, Hassert, Mariah, Steffen, Tara L., Makkena, Taneesh, Smither, Madeleine, Schwetye, Katherine E., Zhang, Jianfeng, Georges, Bertrand, Roberts, M. Scot, Suschak, John J., Pinto, Amelia K., Brien, James D.
Format: Article
Language:English
Subjects:
Immunology
intramuscular vaccination
intranasal vaccination
SARS-CoV-2
vaccine efficacy
vaccine immunogenicity
virus transmission
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionVaccination is the most effective mechanism to prevent severe COVID-19. However, breakthrough infections and subsequent transmission of SARS-CoV-2 remain a significant problem. Intranasal vaccination has the potential to be more effective in preventing disease and limiting transmission between individuals as it induces potent responses at mucosal sites. MethodsUtilizing a replication-deficient adenovirus serotype 5-vectored vaccine expressing the SARS-CoV-2 RBD (AdCOVID) in homozygous and heterozygous transgenic K18-hACE2, we investigated the impact of the route of administration on vaccine immunogenicity, SARS-CoV-2 transmission, and survival. ResultsMice vaccinated with AdCOVID via the intramuscular or intranasal route and subsequently challenged with SARS-CoV-2 showed that animals vaccinated intranasally had improved cellular and mucosal antibody responses. Additionally, intranasally vaccinated animals had significantly better viremic control, and protection from lethal infection compared to intramuscularly vaccinated animals. Notably, in a novel transmission model, intranasal vaccination reduced viral transmission to naïve co-housed mice compared to intramuscular vaccination. DiscussionOur data provide convincing evidence for the use of intranasal vaccination in protecting against SARS-CoV-2 infection and transmission.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1188392